Abstract
Iodine-131 metaiodobenzylguanidine (I-131 MIBG) has been used for the diagnosis and treatment of malignant pheochromocytomas (PHEO) and paragangliomas (PGL) since 1980's. Despite increasing amount of experience with iodine-131 (I-131) MIBG therapy, many important questions still exist. In this article, we will discuss the current problems learned from clinical experience in diagnosis and therapy of PHEO/PGL with I-131 MIBG, and present a sample case to emphasize the critical aspects for an optimal treatment strategy.
Original language | English |
---|---|
Pages (from-to) | 146-152 |
Number of pages | 7 |
Journal | Quarterly Journal of Nuclear Medicine and Molecular Imaging |
Volume | 57 |
Issue number | 2 |
Publication status | Published - Jun 2013 |
Keywords
- Adrenal glands
- Neural crest tumor
- Neuroendocrine tumors
- Positron emission tomography
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging